Here's the live share price of Bacil Pharma along with daily highs, lows, percentage changes and volume trends, and, all financial information.
Over the last 5 years, the share price of Bacil Pharma has gained 42.89% CAGR. Over the past year, the corresponding return has been -22.25%.
Bacil Pharma’s current P/E of 44.81x helps give context to how the market is valuing the stock based on recent earnings and growth expectations. Check out if this stock is part of our Highest YOY Quarterly profit growth Screener.
| Name | 1W(%) | 1M(%) | 3M(%) | 6M(%) | 1Y(%) | 3Y(%) | 5Y(%) | 
|---|---|---|---|---|---|---|---|
| Bacil Pharma | -12.58 | -20.65 | -8.06 | -14.84 | -22.25 | 64.09 | 42.89 | 
| Sun Pharmaceutical Industries | 0.32 | 4.21 | -0.03 | -6.77 | -7.79 | 18.84 | 29.44 | 
| Divi's Laboratories | 1.31 | 16.87 | 1.11 | 9.40 | 13.24 | 22.77 | 16.97 | 
| Cipla | -4.30 | 0.12 | -2.48 | -0.66 | -2.42 | 9.13 | 15.08 | 
| Torrent Pharmaceuticals | 0.49 | 0.92 | -3.90 | 10.43 | 12.30 | 29.66 | 23.10 | 
| Mankind Pharma | 0.05 | -0.24 | -5.26 | 2.13 | -8.77 | 19.54 | 11.31 | 
| Dr. Reddy's Laboratories | -6.43 | -3.59 | -5.46 | 1.57 | -5.71 | 10.67 | 4.34 | 
| Zydus Lifesciences | -2.09 | -0.72 | 1.51 | 11.20 | -1.72 | 31.42 | 19.14 | 
| Lupin | 0.68 | -1.88 | 0.81 | -5.51 | -11.06 | 40.68 | 16.34 | 
| Alkem Laboratories | -0.62 | 0.94 | 9.54 | 8.65 | -4.71 | 20.44 | 15.71 | 
| Aurobindo Pharma | 3.21 | 3.03 | -1.84 | -7.60 | -19.77 | 27.66 | 8.06 | 
| Abbott India | -1.41 | -1.18 | -14.24 | -4.01 | 1.88 | 15.30 | 13.74 | 
| Glenmark Pharmaceuticals | 4.31 | -3.16 | -11.08 | 37.89 | 12.02 | 67.39 | 32.01 | 
| Laurus Labs | 4.19 | 10.54 | 10.27 | 55.40 | 95.97 | 28.47 | 26.23 | 
| Biocon | 4.69 | 8.51 | -3.86 | 18.00 | 18.93 | 11.77 | -1.43 | 
| GlaxoSmithKline Pharmaceuticals | -4.52 | -2.55 | -16.85 | -7.94 | -3.45 | 24.00 | 13.26 | 
| Anthem Biosciences | -0.22 | -6.93 | -5.33 | -1.66 | -1.66 | -0.56 | -0.33 | 
| Ipca Laboratories | 1.06 | -3.50 | -13.03 | -7.05 | -19.30 | 12.31 | 2.18 | 
| Gland Pharma | -1.18 | -3.23 | -7.21 | 36.45 | 16.10 | 2.41 | 1.04 | 
| Ajanta Pharma | 2.70 | 3.33 | -9.90 | -4.10 | -19.32 | 24.06 | 18.74 | 
Over the last one year, Bacil Pharma has declined 22.25% compared to peers like Sun Pharmaceutical Industries (-7.79%), Divi's Laboratories (13.24%), Cipla (-2.42%). From a 5 year perspective, Bacil Pharma has outperformed peers relative to Sun Pharmaceutical Industries (29.44%) and Divi's Laboratories (16.97%).
| Day | SMA | EMA | 
|---|---|---|
| 5 | 40.62 | 38.59 | 
| 10 | 41.32 | 39.78 | 
| 20 | 42.47 | 40.53 | 
| 50 | 40.18 | 40.65 | 
| 100 | 40.9 | 40.78 | 
| 200 | 40.95 | 38.08 | 
In the latest quarter, Bacil Pharma saw a drop in promoter holding to 0.08%, while DII stake unchanged at 0.00%, FII holding unchanged at 0.00%, and public shareholding moved up to 99.92% compared to the previous quarter — reflecting a shift in investor sentiment across categories.
| Date Time | Announcement | 
|---|---|
| Oct 14, 2025, 11:05 PM IST | Bacil Pharma - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 | 
| Sep 30, 2025, 9:23 PM IST | Bacil Pharma - Shareholder Meeting / Postal Ballot-Scrutinizer''s Report | 
| Sep 29, 2025, 7:19 PM IST | Bacil Pharma - Shareholder Meeting / Postal Ballot-Outcome of AGM | 
| Sep 05, 2025, 8:25 PM IST | Bacil Pharma - Book Closure For The Purpose Of Annual General Meeting | 
| Sep 05, 2025, 8:21 PM IST | Bacil Pharma - Reg. 34 (1) Annual Report. | 
Bacil Pharma Ltd. is a Public Limited Listed company incorporated on 08/05/1987 and has its registered office in the State of Maharashtra, India. Company's Corporate Identification Number(CIN) is L24200MH1987PLC043427 and registration number is 043427. Currently company belongs to the Industry of Pharmaceuticals. Company's Total Operating Revenue is Rs. 0.00 Cr. and Equity Capital is Rs. 13.97 Cr. for the Year ended 31/03/2025.
The share price of any company is dynamic and keeps changing depending on the trade initiated. The shares have a fixed opening rate and closing rate. The share price for Bacil Pharma is ₹34.55 as on Oct 31, 2025.
The Bacil Pharma is operating in the Pharmaceuticals and health care Sector. It is classified as a Smallcap stock on the BSE.
The market cap of Bacil Pharma is ₹49.59 Cr as on Oct 31, 2025.
Today’s highest and lowest price of Bacil Pharma are ₹34.55 and ₹34.55.
The 52-week high/low is the highest and lowest price at which Bacil Pharma stock has traded in the past 52-week or nearly a year. The 52-week high of Bacil Pharma is ₹62.56 and 52-week low of Bacil Pharma is ₹31.59 as on Oct 31, 2025.
The Bacil Pharma has shown returns of -4.98% over the past day, -20.65% for the past month, -8.06% over 3 months, -22.25% over 1 year, 64.09% across 3 years, and 42.89% over 5 years.
P/E ratio of and PB ratio of Bacil Pharma are 44.81 and 1.92 on Oct 31, 2025. While the company gives a dividend yield of 0.00 per annum.